Literature DB >> 25386663

The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.

Feifei Tian1,2, Peng Zhou3, Wenyuan Kang2, Li Luo1, Xia Fan1, Jun Yan1, Huaping Liang1.   

Abstract

The enzyme complex IκB kinase (IKK) is an essential activator of NF-κB signaling pathway involved in propagating the cellular response to inflammation. The complex contains two functional subunits IKKα and IKKβ, which are structurally conserved kinases and selective inhibition of them would result in distinct biological effects. However, most existing IKK inhibitors show moderate or high promiscuity for the two homologous kinases. Understanding of the molecular mechanism and biological implication underlying the specific interactions in IKK-ligand recognition is thus fundamentally important for the rational design of selective IKK inhibitors. In the current work, we integrated molecular docking, quantum mechanics/molecular mechanics calculation and Poisson-Boltzmann/surface area analysis to investigate the structural basis and energetic property of the selective binding of small-molecule ligands to IKKα and IKKβ. It was found that the selectivity is primarily determined by the size and topology difference in ATP-binding pocket of IKKα and IKKβ kinase domains; bulky inhibitor molecules commonly have, respectively, low and appropriate affinities towards IKKα and IKKβ, and thus exhibit relatively high selectivity for IKKβ over IKKα, whereas small ligands can only bind weakly to both the two kinases with low selectivity. In addition, the conformation, arrangement and distribution of residues in IKK pockets are also responsible for constituting the exquisite specificity of ligand binding to KKα and IKKβ. Next, a novel quantitative structure-selectivity relationship model was developed to characterize the relative contribution of each kinase residue to inhibitor selectivity and to predict the selectivity and specificity for a number of known IKK inhibitors. Results showed that the active-site residues contribute significantly to the selectivity by directly interacting with inhibitor ligands, while those protein portions far away from the kinase active sites may also play an important role in determining the selectivity through long-range non-bonded forces and indirect allosteric effect.

Entities:  

Keywords:  IKKα/IKKβ; NF-κB; inflammation; ligand selectivity; small-molecule inhibitor

Mesh:

Substances:

Year:  2014        PMID: 25386663     DOI: 10.3109/10799893.2014.980950

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

1.  Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.

Authors:  Min Han; Dongdong Sun
Journal:  J Comput Aided Mol Des       Date:  2019-06-15       Impact factor: 3.686

2.  Distinct outcomes of CRL-Nedd8 pathway inhibition reveal cancer cell plasticity.

Authors:  Anastasia V Rulina; Frédérique Mittler; Patricia Obeid; Sophie Gerbaud; Laurent Guyon; Eric Sulpice; Frédérique Kermarrec; Nicole Assard; Monika E Dolega; Xavier Gidrol; Maxim Y Balakirev
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

3.  Repurposing Thioridazine (TDZ) as an anti-inflammatory agent.

Authors:  Mirza S Baig; Anjali Roy; Uzma Saqib; Sajjan Rajpoot; Mansi Srivastava; Adnan Naim; Dongfang Liu; Rohit Saluja; Syed M Faisal; Qiuwei Pan; Kati Turkowski; Gajanan N Darwhekar; Rajkumar Savai
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

4.  INH14, a Small-Molecule Urea Derivative, Inhibits the IKKα/β-Dependent TLR Inflammatory Response.

Authors:  Meinrad Drexel; Johannes Kirchmair; Sandra Santos-Sierra
Journal:  Chembiochem       Date:  2019-01-29       Impact factor: 3.164

5.  A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma.

Authors:  Huan Ding; Huan Hu; Feifei Tian; Huaping Liang
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

6.  BMS‑345541 inhibits airway inflammation and epithelial‑mesenchymal transition in airway remodeling of asthmatic mice.

Authors:  Xiaohua Zhu; Qiugen Li; Guozhu Hu; Jun Wang; Qinghua Hu; Zhiqiang Liu; Gang Wu; Ying Zhong
Journal:  Int J Mol Med       Date:  2018-07-06       Impact factor: 4.101

Review 7.  DNA Nanostructure as an Efficient Drug Delivery Platform for Immunotherapy.

Authors:  Qingjia Chi; Zichang Yang; Kang Xu; Chunli Wang; Huaping Liang
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.